Anne Kennedy is a Managing Director at Deloitte, specializing in strategy and business transformation. Her career is marked by leadership in redesigning operating models, mitigating risk, and spearheading acquisition integrations for global Fortune 500 companies. She holds an M. S. from the University of Pennsylvania and a certification from Stanfords Graduate School of Business.
Anne maintains strong connections to the academic and business thought leadership communities, following institutions like the University of Southern California and publications such as Harvard Business Review. Her professional interests extend into the medical technology sector, indicating a focus on healthcare innovation and strategy.
Unique fact: As Chief Transformation Officer at Alexion Pharmaceuticals, she reported directly to the CEO and Board of Directors.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.